- Home
- YALA vs IMTX Comparison
YALA vs IMTX Comparison
Compare YALA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- IMTX
- Stock Information
- Founded
- YALA 2016
- IMTX N/A
- Country
- YALA United Arab Emirates
- IMTX Germany
- Employees
- YALA N/A
- IMTX N/A
- Industry
- YALA Computer Software: Programming Data Processing
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YALA Technology
- IMTX Health Care
- Exchange
- YALA Nasdaq
- IMTX Nasdaq
- Market Cap
- YALA 1.2B
- IMTX 1.1B
- IPO Year
- YALA 2020
- IMTX N/A
- Fundamental
- Price
- YALA $7.54
- IMTX $9.12
- Analyst Decision
- YALA
- IMTX Strong Buy
- Analyst Count
- YALA 0
- IMTX 4
- Target Price
- YALA N/A
- IMTX $13.67
- AVG Volume (30 Days)
- YALA 394.6K
- IMTX 633.9K
- Earning Date
- YALA 11-10-2025
- IMTX 11-14-2025
- Dividend Yield
- YALA N/A
- IMTX N/A
- EPS Growth
- YALA 14.19
- IMTX N/A
- EPS
- YALA 0.81
- IMTX N/A
- Revenue
- YALA $348,190,638.00
- IMTX $152,823,253.00
- Revenue This Year
- YALA $3.95
- IMTX N/A
- Revenue Next Year
- YALA $10.18
- IMTX $13.52
- P/E Ratio
- YALA $8.89
- IMTX N/A
- Revenue Growth
- YALA 6.79
- IMTX 83.61
- 52 Week Low
- YALA $3.83
- IMTX $3.30
- 52 Week High
- YALA $9.29
- IMTX $11.25
- Technical
- Relative Strength Index (RSI)
- YALA 58.04
- IMTX 44.49
- Support Level
- YALA $6.99
- IMTX $8.69
- Resistance Level
- YALA $7.83
- IMTX $10.70
- Average True Range (ATR)
- YALA 0.26
- IMTX 0.49
- MACD
- YALA 0.04
- IMTX -0.28
- Stochastic Oscillator
- YALA 78.57
- IMTX 15.60
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.